4 completed, 1 unknown. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 4, Unknown 1 |
Follow Lexiscan: new trials by email Literature Review of Lexiscan trials Research Report on Lexiscan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT) Regadenoson, Single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) - Coronary Artery Disease (CAD) | Phase 3 | Completed | Astellas Pharma Global Development, Inc. | 1147 | 2012-06-01 | 2016-02-08 |
| Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) regadenoson, overencapsulated caffeine, technetium - Coronary Artery Disease (CAD) | Phase 3 | Completed | Astellas Pharma Inc | 347 | 2009-03-24 | 2024-12-03 |
| Myocardial Perfusion Assessment With Multidetector Computed Tomography Regadenoson (Lexiscan) [muti-detector computed tomography] - Coronary Artery Disease | Phase 3 | Unknown | Tennessee Heart and Vascular Institute, P.C. | 100 | 2009-02-01 | 2009-02-18 |
| ADVANCE MPI 2: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI) Regadenoson, Adenosine - Coronary Artery Disease | Phase 3 | Completed | Gilead Sciences | 787 | 2004-04-01 | 2009-11-26 |
| ADVANCE MPI 1: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI) Regadenoson, Adenosine - Coronary Artery Disease | Phase 3 | Completed | Gilead Sciences | 1231 | 2003-10-01 | 2009-11-26 |
Coronary Artery Disease (5) · Ischemia (1)
Gilead Sciences (2) · Astellas Pharma Global Development, Inc. (1) · Astellas Pharma Inc (1) · Tennessee Heart and Vascular Institute, P.C. (1)
United States (5) · Argentina (1) · Peru (1) · Puerto Rico (1)